earnings
confidence high
sentiment positive
materiality 0.85
Charles River Q2 revenue $914.6M (+34% YoY); raises 2021 guidance above prior estimates
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
2021-Q2 EPS reported
$2.93
revenue$1,739,173,000
- Revenue $914.6M, +34% YoY (organic +24.1%); GAAP EPS $1.72, non-GAAP EPS $2.61.
- Non-GAAP EPS of $2.61 beat prior year $1.58; net income $88.4M GAAP, $133.8M non-GAAP.
- All three segments drove organic growth: RMS +44.5%, DSA +18.1%, Manufacturing +26.6%.
- 2021 guidance raised: revenue growth 20.5-22.5% (was 19-21%), non-GAAP EPS $10.10-$10.35 (was $9.75-$10.00), FCF ~$500M.
- CEO cites robust client demand and strengthened portfolio; company adding staff and capacity.